INS and type 1 diabetes mellitus: Different islet autoantibodies (aAbs) may characterize the period preceding T1D clinical onset, aAbs against islets antigens such as insulin, glutamic acid decarboxylase (GAD65), insulinoma associated protein-2, and zinc transporter 8 (ZnT8) may be detectable for months up to years before disease onset.